leisure time -WSS

leisure time

author：fashion 2025-09-30 06:09:19 - browse：2

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： FDA approves world's first CRISPR

hotspot

WSS

Leukemia patients are helped by Syndax's new type of therapy

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Patients' immediate access to test results puts radiologists in a bind

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

In diabetes hearing, Sanders takes on a new foe: food makers

Solving academic medical centers' existential crisis

focus

leisure time

entertainment

Bright Health sells Medicare Advantage business to Molina

Cytokinetics CEO stresses company can launch heart drug on its own

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Hollywood unions extend contract negotiations for actors

Why sickle cell disease is getting the first CRISPR treatment

ChatGPT in medicine: STAT answers readers' burning questions

Second House panel advances two

Tori Bowie and the unacceptable rates of Black maternal death

Radiology is caught between AI's potential and concern for patients

knowledge

HIV vaccine remains elusive. Immunologists keep trying new ideas

Venture capitalist Bob Kocher on the state of digital health

AI models in health care face new federal disclosure requirements

Arc Institute generative AI designs new CRISPR systems

Americans' trust in science, scientist continues decline: Report

Americans' trust in science, scientist continues decline: Report

hotspot

hotspot

entertainment

entertainment